CytomX
CytomX is an early-stage biotechnology company that develops antibody based therapeutics for the treatment of cancer and inflammatory diseases.
Business Model:
Revenue: $71.9M
Employees: 51-200
Industries / Tags:
Detailed CytomX Information
Geographic Data
Address: 151 Oyster Point Boulevard
City: South San Francisco
State: CA
Zip: 94080
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$94M
Raised Total:$291M
Social
Metrics
77,564Website Global Rank
1,622,290Website Monthly Traffic
Twitter Followers
Description
CytomX is an early-stage biotechnology company that develops antibody based therapeutics for the treatment of cancer and inflammatory diseases.
Contact Phone:
+16505153185
Contact Email:
CytomX went public on 10/8/2015 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
10/8/2015
Ticker Symbol:
CTMX
IPO Price:
$12/share
Amount Raised:
$80M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 3/2005 | Ardais Corporation |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
